Answers are grounded in this paper and cite their sources.
Several concepts explaining the phenomenon of the nitroglycerin migration from DB and CMDB propellants to the inhibitor, are presented in this review. In the light of these concepts and the data available in the literature, methods to prevent/reduce NG migration are also discussed.
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: